The data shown below were collected from the profiles of 157 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer
|
---|---|
Published in |
Oncogene, September 2023
|
DOI | 10.1038/s41388-023-02835-y |
Pubmed ID | |
Authors |
Pashtoon Murtaza Kasi, Manuel Hidalgo, Mehraneh D. Jafari, Heather Yeo, Lea Lowenfeld, Uqba Khan, Alana T. H. Nguyen, Despina Siolas, Brandon Swed, Jini Hyun, Sahrish Khan, Madeleine Wood, Benjamin Samstein, Juan P. Rocca, Allyson J. Ocean, Elizabeta C. Popa, Daniel H. Hunt, Nikhil P. Uppal, Kelly A. Garrett, Alessio Pigazzi, Xi Kathy Zhou, Manish A. Shah, Erika Hissong |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 44 | 28% |
United Kingdom | 8 | 5% |
India | 6 | 4% |
Brazil | 6 | 4% |
Mexico | 5 | 3% |
Canada | 5 | 3% |
Germany | 4 | 3% |
Australia | 3 | 2% |
Ireland | 2 | 1% |
Other | 19 | 12% |
Unknown | 55 | 35% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 93 | 59% |
Scientists | 32 | 20% |
Practitioners (doctors, other healthcare professionals) | 31 | 20% |
Science communicators (journalists, bloggers, editors) | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 18 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 4 | 22% |
Researcher | 3 | 17% |
Student > Bachelor | 2 | 11% |
Lecturer | 1 | 6% |
Professor > Associate Professor | 1 | 6% |
Other | 1 | 6% |
Unknown | 6 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 6 | 33% |
Biochemistry, Genetics and Molecular Biology | 2 | 11% |
Unspecified | 1 | 6% |
Agricultural and Biological Sciences | 1 | 6% |
Design | 1 | 6% |
Other | 0 | 0% |
Unknown | 7 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 526. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 October 2024.
All research outputs
#51,774
of 26,794,105 outputs
Outputs from Oncogene
#6
of 11,342 outputs
Outputs of similar age
#1,082
of 367,682 outputs
Outputs of similar age from Oncogene
#1
of 67 outputs
Altmetric has tracked 26,794,105 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,342 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 367,682 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 67 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.